ReviewOncoTargets and therapy2023

FMS-Like Tyrosine Kinase 3 Inhibitors in the Treatment of Acute Myeloid Leukemia: An Update on the Emerging Evidence and Safety Profile.

Sylvain Garciaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.